Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine if an investigational treatment is effective compared with placebo and PVP-Iodine in the treatment of adults and children with adenoviral conjunctivitis.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT02998541
Study type Interventional
Source Takeda
Status Terminated
Phase Phase 3
Start date March 27, 2017
Completion date May 13, 2019

See also
  Status Clinical Trial Phase
Completed NCT01532336 - Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis Phase 2
Terminated NCT02998554 - Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo Phase 3
Completed NCT02472223 - Reducing Adenoviral Patient Infected Days N/A
Terminated NCT00901693 - An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis Phase 2
Withdrawn NCT03009799 - Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) Phase 2
Active, not recruiting NCT03856645 - OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis Phase 2
Completed NCT00266734 - Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears N/A
Recruiting NCT03749317 - Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis Phase 2